Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients. 1982

H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young

The authors determined the platelet MAO activity of 57 psychotic patients after a placebo period and after 3-65 days of neuroleptic treatment. Platelet MAO activity significantly decreased in both men and women after neuroleptic treatment. The platelet MAO activity of neuroleptic-treated schizophrenic women was significantly less than that of drug-free schizophrenic women, who did not differ from normal women. There were trends in the same direction for the schizophrenic men. Previous studies that reported lower platelet MAO activity in neuroleptic-treated schizophrenic patients than in normal controls may have been influenced by this neuroleptic effect.

UI MeSH Term Description Entries
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
February 1981, Psychiatry research,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
October 1982, Psychiatry research,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
December 1974, The American journal of psychiatry,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
January 1980, Schizophrenia bulletin,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
August 1975, British journal of clinical pharmacology,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
October 1987, Psychiatry research,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
December 1984, Journal of clinical psychopharmacology,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
December 1977, Biochemical medicine,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
August 1979, Biochemical medicine,
H Y Meltzer, and M B Duncavage, and H Jackman, and R C Arora, and B J Tricou, and M Young
January 1989, General pharmacology,
Copied contents to your clipboard!